Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02857478 · ClinicalTrials.gov registry record · NA
Supervised Outdoor-Use Test to Assess the Safety of a Sunscreen C-Spray on Sport Users
A NA study of Sunscreen Agents, sponsored by Bayer.
- Completed
- Registry status
- NA
- Development phase
- 98
- Enrollment target
- 1
- Study location
NCT02857478: Completed NA study of Sunscreen Agents, sponsored by Bayer.
NCT02857478 is a NA study of Sunscreen Agents that has completed, run by Bayer. The registered enrollment target is 98 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02857478, a NA study of Sunscreen Agents, has completed, sponsored by Bayer.
- COMPLETED
- Registry status
- NA
- Development phase
- 98 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this study was to assess the safety and appropriateness of a sunscreen product for use on sport users, under supervised outdoor-use conditions. The study was conducted under the supervision of a Board-Certified Dermatologist at an outdoor, chlorinated swimming pool facility.
Conditions Studied
Interventions
- DRUG BAY 987519, SPF 50, Y51-002
- DRUG BAY 987519, SPF 50, P04-147
Study Locations (1)
Florida
- - St. Petersburg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 98 participants |
| Start Date | 2015-06-27 |
| Est. Completion | 2015-06-28 |
| Phase | NA |
What the finished NCT02857478 record still lists
NCT02857478 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 98 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).
The record links to 1 condition, with Sunscreen Agents appearing as the primary indexed condition, and to 2 interventions - of which BAY 987519, SPF 50, Y51-002 is the first listed.
NCT02857478 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT02857478 about?
NCT02857478 is a clinical study titled "Supervised Outdoor-Use Test to Assess the Safety of a Sunscreen C-Spray on Sport Users". The objective of this study was to assess the safety and appropriateness of a sunscreen product for use on sport users, under supervised outdoor-use conditions. The study was conducted under the supervision of a Board-Certified Dermatologist at an outdoor, chlorinated swimming pool facility.
What is the current status of trial NCT02857478?
This trial is currently completed. It is a NA study. The enrollment target is 98 participants. The study started on 2015-06-27. Estimated completion is 2015-06-28.
What conditions does trial NCT02857478 study?
This clinical trial studies the following conditions: Sunscreen Agents.
What interventions are being tested in trial NCT02857478?
The interventions under investigation include: BAY 987519, SPF 50, Y51-002 (DRUG), BAY 987519, SPF 50, P04-147 (DRUG).
Who is sponsoring clinical trial NCT02857478?
This trial is sponsored by Bayer, which has 591 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02857478 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sunscreen Agents
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02857478's enrollment target sits among peer trials
98 922nd of 2000 higher than 1,078 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02926729 · 98 participants · NA
Real-Time Assessment Of Breast Cancer Lumpectomy Specimen Margins With Nonlinear Microscopy
- NCT03382977 · 98 participants · Phase 1
Study to Evaluate Safety, Tolerability, and Optimal Dose of Candidate GBM Vaccine VBI-1901 in Recurrent GBM Subjects
- NCT04577014 · 98 participants · Phase 1
Retifanlimab (Anti-PD-1 Antibody) With Gemcitabine and Docetaxel in Patients With Advanced Soft Tissue Sarcoma
- NCT04817618 · 98 participants · Phase 3
Study of Efficacy and Safety of Iptacopan in Patients With C3 Glomerulopathy.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI